von Willebrand's disease and plastic surgery.
【연구 목적】 혈전성 질환 중 가장 흔한 유전성 질환인 폰빌레브란트병(Von Willebrand's disease, VWD)이 성형외과 환자군에서 얼마나 발생하며, 이를 효과적으로 관리하기 위한 임상적 접근법을 규명하는 것이 본 연구의 목적이다.
APA
Guyuron B, Zarandy S, Tirgan A (1994). von Willebrand's disease and plastic surgery.. Annals of plastic surgery, 32(4), 351-5. https://doi.org/10.1097/00000637-199404000-00004
MLA
Guyuron B, et al.. "von Willebrand's disease and plastic surgery.." Annals of plastic surgery, vol. 32, no. 4, 1994, pp. 351-5.
PMID
8210151
Abstract
Von Willebrand's disease (VWD) is the most commonly inherited coagulopathy. In a group of 1,000 plastic surgery patients, 8 or 9 individuals are affected by this disease, making basic knowledge of VWD and its management imperative. In this investigation, 1,000 plastic surgery patients were studied for details of their clinical evaluation, history of bleeding and bruising, and excessive bleeding during or after surgery. If the patient reported a history of easy bleeding or bruising, in addition to routine coagulation studies such as PT, PTT, and platelet count, the bleeding time was measured. When the index of suspicion dictated, more extensive coagulation studies, such as factor VIII assay, were conducted. This resulted in the detection of VWD in 9 patients (8 female and 1 male). All patients had a positive history of easy bleeding or bruising. Six of the 9 patients had a bleeding time greater than 6 minutes. Seven patients were diagnosed to have VWD type I, 1 had type II-a, and 1 suffered from type II-b disease. Perioperative bleeding was controlled in all patients in this study with the administration of 0.3 microgram/kg of body weight (usually a total dose of 20 micrograms) of 1-deamino-8-D-arginine-vasopressin intravenously every 12 hours for the first 24 hours. Two patients with type II VWD required fresh frozen plasma and cryoprecipitate 1 week subsequent to surgery to control late bleeding.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 해부 | body
|
scispacy | 1 | ||
| 약물 | 1-deamino-8-D-arginine-vasopressin
|
C0011701
desmopressin
|
scispacy | 1 | |
| 질환 | Willebrand's disease
|
C0042974
von Willebrand Disease
|
scispacy | 1 | |
| 질환 | VWD
→ Von Willebrand's disease
|
C0042974
von Willebrand Disease
|
scispacy | 1 | |
| 질환 | coagulopathy
|
C0005779
Blood Coagulation Disorders
|
scispacy | 1 | |
| 질환 | bleeding
|
C0019080
Hemorrhage
|
scispacy | 1 | |
| 질환 | bruising
|
C0009938
Contusions
|
scispacy | 1 | |
| 질환 | type II VWD
|
scispacy | 1 | ||
| 질환 | von Willebrand
|
scispacy | 1 | ||
| 질환 | disease
|
scispacy | 1 | ||
| 기타 | PTT
|
scispacy | 1 | ||
| 기타 | platelet count
|
scispacy | 1 | ||
| 기타 | factor VIII
|
scispacy | 1 | ||
| 기타 | type II VWD
|
scispacy | 1 | ||
| 기타 | cryoprecipitate 1
|
scispacy | 1 |
MeSH Terms
Adolescent; Adult; Blood Coagulation Factors; Female; Humans; Male; Middle Aged; Preoperative Care; Retrospective Studies; Surgery, Plastic; von Willebrand Diseases